Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris

References

• Wood CR, Boss MA, Kenten JH, Calvert JE, Roberts NA. The synthesis and in vivo assembly of functional antibodies in yeast. Nature 1985; 314:446 - 449
   PubMed Web of Science ®Google Scholar
• Horwitz AH, Chang CP, Better M, Hellstrom KE, Robinson RR. Secretion of functional antibody and Fab fragment from yeast cells. Proc Natl Acad Sci USA 1988; 85:8678 - 8682
   PubMed Web of Science ®Google Scholar
• Ogunjimi AA, Chandler JM, Gooding CM, Recinos A, Choudary PV. High-level secretory expression of immunologically active intact antibody from the yeast Pichia pastoris. Biotechnol Lett 1999; 21:561 - 567
   Web of Science ®Google Scholar
• Ridder R, Schmitz R, Legay F, Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Nature Biotechnol 1995; 13:255 - 260
   Web of Science ®Google Scholar
• Luo D, Mah N, Krantz M, Wilde K, Wishart D, Zhang Y, et al. VI-linker-Vh orientation-dependent expression of single chain Fv containing an engineered disulfide-stabilized bond in the framework regions. J Biochem 1995; 118:825 - 831
   PubMed Web of Science ®Google Scholar
• Ando K, Arunwanich P, Kai K, Shinkai M, Honda H, Kobayashi T. Production of Fv fragment of monoclonal antibody from recombinant methylotrophic yeast, Pichia pastoris. J Chem Eng Jpn 1996; 29:390 - 392
   Web of Science ®Google Scholar
• Luo D, Geng M, Noujaim AA, Madiyalakan R. An engineered bivalent single-chain antibody fragment that increases antigen binding activity. J Bicohem 1997; 121:831 - 834
   PubMed Web of Science ®Google Scholar
• Luo D, Mah N, Krantz M, Wishart D, Jacobs F, Martin L. High level secretion of single-chain antibody in Pichia exression system. Biotechnol Tech 1997; 11:759 - 761
   Google Scholar
• Goel A, Beresford GW, Colcher D, Pavlinkova G, Booth BJM, Baranowska-Kortylewicz J, et al. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification and characterization. J Biochem 2000; 127:829 - 836
   PubMed Web of Science ®Google Scholar
• Andrade EV, Albuquerque FC, Moraes LMP, Brigido MM, Santos-Silva MA. Single-chain Fv with Fc fragment of the human IgG1 tag: construction, Pichia pastoris expression and antigen binding characterization. J Biochem 2000; 128:891 - 895
   PubMed Web of Science ®Google Scholar
• Freyre FM, Vazquez JE, Ayala M, Canaan-Haden L, Bell H, Rodriguez I, et al. Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris. J Biotechnol 2000; 76:157 - 163
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yuuki T, Takai T, Ra C, Okumura K, Yokota T, et al. Production of humanized Fab fragment against human high affinity IgE receptor in Pichia pastoris. Biosci Biotechnol Biochem 2000; 64:2138 - 2144
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang K, Jette DC, Wishart DS. Production of an anti-prostate-specific antigen single-chain antibody fragment from Pichia pastoris. Protein Expres Purif 2001; 23:419 - 425
   PubMed Web of Science ®Google Scholar
• Lange S, Schmitt J, Schmid RD. High-yield expression of the recombinant, atrazine-specific Fab fragment K411B by the methylotrophic yeast Pichia pastoris. J Immunol Methods 2001; 255:103 - 114
   PubMed Web of Science ®Google Scholar
• Shapiro RI, Wen D, Levesque M, Hronowski X, Gill A, Garber EA, et al. Expression of sonic hedgehog-Fc fusion protein in Pichia pastorsi. Identification and control of post-translational, chemical and proteolytic modifications. Protein Expres Purif 2003; 29:272 - 283
   PubMed Web of Science ®Google Scholar
• Hu S, Li L, Qiao J, Guo Y, Cheng L, Liu J. Codon optimization, expression and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris. Protein Expres Purif 2006; 47:249 - 257
   PubMed Web of Science ®Google Scholar
• Tanfous NGB, Kallel H, Jarboui MA, Fathallah DM. Expression in Pichia pastoris of a recombinant scFv form of mAb 107, an anti human CD11b integrin antibody. Enzyme Microb Technol 2006; 38:636 - 642
   Web of Science ®Google Scholar
• Gasser B, Maurer M, Gach J, Kunert R, Mattanovich D. Engineering of Pichia pastoris for improved production of antibody fragments. Biotechnol Bioeng 2006; 94:353 - 361
   PubMed Web of Science ®Google Scholar
• Lin H, Kim T, Xiong F, Yang X. Enhancing the production of Fc fusion protein in fed-batch fermentation of Pichia pastoris by design of experiments. Biotechnol Prog 2007; 23:621 - 625
   PubMed Web of Science ®Google Scholar
• Cai J, Li F, Wang SZ. Expression of secreted human single-chain fragment variable antibody against human amyloid beta peptide in Pichia patoris. Neural Regen Res 2008; 3:910 - 913
   Web of Science ®Google Scholar
• Chang HJ, Choi SW, Chun HS. Expression of functional single-chain variable domain fragment antibody (scFv) against mycotoxin zearalenone in Pichia pastoris. Biotechnol Lett 2008; 30:1801 - 1806
   PubMed Web of Science ®Google Scholar
• Kunert R, Gach J, Katinger H. Expression of a Fab fragment in CHO and Pichia pastoris. BioProcess Int 2008; 6:34 - 36
   Google Scholar
• Schoonooghe S, Kaigorodov V, Zawisza M, Dumolyn C, Haustraete J, Grooten J, et al. Efficient production of human bivalent and trivalent anti-MUCI Fab-scFv antibodies in Pichia pastoris. BMC Biotechnol 2009; 9:70
   PubMed Web of Science ®Google Scholar
• Callewaert N, Laroy W, Cadirgi H, Geysens S, Saelens X, Jou WM, Contreras R. Use of HDEL-tagged Trichoderma reesei mannosyl oligosaccharide 1,2-α-D-mannosidase for N-glycan engineering in Pichia pastoris. FEBS Lett 2001; 503:173 - 178
   PubMed Web of Science ®Google Scholar
• Vervecken W, Kaigorodov V, Callewaert N, Geysens S, Vusser KD, Contreras R. In vivo synthesis of mammalian-like, hybrid-type N-glycans in Pichia pastoris. Appl Environ Microbiol 2004; 70:2639 - 2646
   PubMed Web of Science ®Google Scholar
• Choi BK, Bobrowicz P, Davidson RC, Hamilton SR, Kung DH, Li H, et al. Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris. Proc Natl Acad Sci USA 2003; 100:5022 - 5027
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, et al. Production of complex human glycoproteins in yeast. Science 2003; 301:1244 - 1246
   PubMed Web of Science ®Google Scholar
• Bobrowicz P, Davidson RC, Li H, Potgieter TI, Nett JH, Hamilton SR, et al. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. Glycobiology 2004; 14:757 - 766
   PubMed Web of Science ®Google Scholar
• Gerngross TU. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nature Biotechnol 2004; 22:1409 - 1414
   PubMed Web of Science ®Google Scholar
• Wildt S, Gerngross TU. The humanization of N-glycosylation pathways in yeast. Nat Rev Microbiol 2005; 3:119 - 128
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz P, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science 2006; 313:1441 - 1443
   PubMed Web of Science ®Google Scholar
• Li H, Sethuraman N, Stadheim TA, Zha D, Prinz B, Ballew N, et al. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nature Biotechnol 2006; 24:210 - 215
   PubMed Web of Science ®Google Scholar
• Jacobs PP, Geysens S, Vervecken W, Contreras R, Callewaert N. Engineering complex-type N-glycosylation in pichia pastoris using GlycoSwitch technology. Nat Protocols 2009; 4:58 - 70
   PubMed Web of Science ®Google Scholar
• Potgieter TI, Cukan M, Drummond JE, Houston-Cummings NR, Jiang Y, Li F, et al. Production of monoclonal antibodies by glycoengineered Pichia pastoris. J Biotechnol 2009; 139:318 - 325
   PubMed Web of Science ®Google Scholar
• Barnard GC, Kull AR, Sharkey NS, Shaikh SS, Rittenhour AM, Burnina I, et al. High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies. J Ind Microbiol Biotechnol 2010; 37:961 - 971
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li F, Zha D, Potgieter T, Mitchell T, Moore R, et al. Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris. Protein Expr Purif 2011; 76:7 - 14
   PubMed Web of Science ®Google Scholar
• Pinckard RN, Weir DM, McBride WH. Factors influencing the immune response. I. Effects of the physical state of the antigen and of lymphoreticular cell proliferation on the response to intravenous injection of bovine serum albumin in rabbits. Clin Exp Immunol 1967; 2:331 - 341
   PubMedGoogle Scholar
• Moore WV, Leppert P. Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. J Clin Endocrinol Metabolism 1980; 51:691 - 697
   PubMed Web of Science ®Google Scholar
• Robbins DC, Cooper SM, Fineberg SE, Mead PM. Antibodies to covalent aggregates of insulin in blood of insulin-using diabetic patients. Diabetes 1987; 36:838 - 841
   PubMed Web of Science ®Google Scholar
• Frost H. Antibody-mediated side effects of recombinant proteins. Toxicology 2005; 209:155 - 160
   PubMed Web of Science ®Google Scholar
• Arakawa T, Philo JS, Ejima D, Tsumoto K, Arisaka F. Aggregation analysis of therapeutic proteins, Part 1: General aspects and techniques for assessment. Bioprocess Int 2006; 4:32 - 43
   Google Scholar
• Arakawa T, Philo JS, Ejima D, Tsumoto K, Arisaka F. Aggregation analysis of therapeutic proteins, Part 2: Analytical Ultracentrifugation and dynamic light scattering. Bioprocess Int 2007; 5:36 - 50
   Google Scholar
• Krishnamurthy R, Sukumar M, Das TK, Lacher NA. Emerging analytical technologies for biotherapeutics development. BioProcess Int 2008; 6:32 - 43
   Google Scholar
• Cohen SL, Price C, Vlasak J. β-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J Am Chem Soc 2007; 129:6976 - 6977
   PubMed Web of Science ®Google Scholar
• Santora LC, Krull IS, Grant K. Characterization of recombinant human monoclonal tissue necrosis factor-α antibody using cation-exchange HPLC and capillary isoelectric focusing. Anal Biochem 1999; 275:98 - 108
   PubMed Web of Science ®Google Scholar
• Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, et al. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chrom B 2001; 752:233 - 245
   PubMed Web of Science ®Google Scholar
• Mario N, Baudin B, Aussel C, Giboudeau J. Capillary isoelectric focusing and high-performance cation-exchange chromatography compared for qualitative and quantitative analysis of hemoglobin variants. Clin Chem 1997; 43:2137 - 2142
   PubMed Web of Science ®Google Scholar
• Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, et al. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 2009; 392:145 - 154
   PubMed Web of Science ®Google Scholar
• Li N, Kessler K, Bass L, Zeng D. Evaluation of the iCE280 Analyzer as a potential high-throughput tool for formulation development. J Pharm Biomed Anal 2007; 43:963 - 972
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Xiang T, Chumsae C. Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody. Mol Immunol 2008; 45:701 - 708
   PubMed Web of Science ®Google Scholar
• Lam XM, Yang JY, Cleland JL. Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. J Pharm Sci 1997; 86:1250 - 1255
   PubMed Web of Science ®Google Scholar
• Chumsae C, Gaza-Bulseco G, Sun J, Liu H. Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 850:285 - 294
   PubMed Web of Science ®Google Scholar
• Bertolotti-Ciarlet A, Wang W, Lownes R, Pristatsky P, Fang Y, McKelvey T, et al. Impact of methionine oxidation on the binding of human IgG1 to FcRn and Fc γ receptors. Mol Immunol 2009; 46:1878 - 1882
   PubMed Web of Science ®Google Scholar
• Wang W, Vlasak J, Li Y, Pristatsky P, Fang Y, Pittman T, et al. Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. Mol Immunol 2011; 48:860 - 866
   PubMed Web of Science ®Google Scholar
• Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci 2009; 18:424 - 433
   PubMed Web of Science ®Google Scholar
• Han M, Phan D, Nightlinger N, Taylor L, Jankhah S, Woodruff B, et al. Optimization of CE-SDS method for antibody separation based on multi-users experimental practices. Chromatographia 2006; 64:335 - 342
   Web of Science ®Google Scholar
• Rustandi RR, Washabaugh MW, Wang Y. Applications of CE SDS gel in development of biopharmaceutical antibody-based products. Electrophoresis 2008; 29:3612 - 3620
   PubMed Web of Science ®Google Scholar
• Ha S, Ou Y, Vlasak J, Li Y, Wang S, Vo K, et al. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. Glycobiology 2011; 21:1087 - 1096
   PubMed Web of Science ®Google Scholar
• Huhn C, Selman MHJ, Ruhaak LR, Deelder AM, Wuhrer M. IgG glycosylation analysis. Proteomics 2009; 9:882 - 913
   PubMed Web of Science ®Google Scholar
• Jefferis R. Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 2005; 21:11 - 16
   PubMed Web of Science ®Google Scholar
• Qian J, Liu T, Yang L, Daus A, Crowley R, Zhou Q. Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal Biochem 2007; 364:8 - 18
   PubMed Web of Science ®Google Scholar
• Chung CH, Mirakhur B, Chan E, Le QT, Berlin J, Morse M, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose. N Engl J Med 2008; 358:1109 - 1117
   PubMed Web of Science ®Google Scholar
• Li H, Miele RG, Mitchell TI, Gerngross TU. N-linked glycan characterization of heterologous proteins. Methods Mol Biol 2007; 389:139 - 150
   PubMedGoogle Scholar
• Gong B, Cukan M, Fisher R, Li H, Stadheim TA, Gerngross T. Packer NH, Karlsson NG. Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF. Methods in Molecular Biology, Glycomics: Methods and Protocols 2009; 534:Humana Press 213 - 223
   Google Scholar
• Zhang N, Liu L, Dumitru CD, Cummings NRH, Cukan M, Jiang Y, et al. Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study. mAbs 2011; 3:289 - 298
   PubMed Web of Science ®Google Scholar
• Ma S, Nashabeh W. Carbohydrate analysis of a chimeric recombinant monoclonal antibody by capillary electrophoresis with laser-induced fluorescence detection. Anal Chem 1999; 71:5185 - 5192
   PubMed Web of Science ®Google Scholar
• Liu Y, Salas-Solano O, Gennaro LA. Investigation of sample preparation artifacts formed during the enzymatic release of N-linked glycans prior to analysis by capillary electrophoresis. Anal Chem 2009; 81:6823 - 6829
   PubMed Web of Science ®Google Scholar
• Duman JG, Miele RG, Liang H, Grella DK, Sim KL, Castellino KJ, et al. O-mannosylation of Pichia pastoris cellular and recombinant proteins. Biotechnol Appl Biochem 1998; 28:39 - 45
   PubMed Web of Science ®Google Scholar
• Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 1997; 272:2156 - 2162
   PubMed Web of Science ®Google Scholar
• Sasaki T, Yamada H, Matsumura K, Shimizu T, Kobata A, Endo T. Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim Biophys Acta 1998; 1425:599 - 606
   PubMed Web of Science ®Google Scholar
• Smalheiser NR, Haslam SM, Sutton-Smith M, Morris HR, Dell A. Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J Biol Chem 1998; 273:23698 - 23703
   PubMed Web of Science ®Google Scholar
• Lommel M, Strahl S. Protein O-mannosylation: conserved from bacteria to humans. Glycobiology 2009; 19:816 - 828
   PubMed Web of Science ®Google Scholar
• Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 2006; 119:199 - 207
   PubMed Web of Science ®Google Scholar
• Kim H, Yamaguchi Y, Masuda K, Matsunaga C, Yamamoto K, Irimura T, et al. O-glycosylation in hinge region of mouse immunoglobin G2b. J Biol Chem 1994; 269:12345 - 12350
   PubMed Web of Science ®Google Scholar
• Arnold JN, Radcliffe CM, Wormald MR, Royle L, Harvey DJ, Crispin M, et al. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol 2004; 173:6831 - 6840
   PubMed Web of Science ®Google Scholar
• Martinez T, Pace D, Brady L, Gerhart M, Balland A. Characterization of a novel modification on IgG2 light chain evidence for the presence of O-linked mannosylation. J Chrom A 2007; 1156:183 - 187
   PubMed Web of Science ®Google Scholar
• Girrbach V, Strahl S. Members of the evolutionarily conserved PMT family of protein O-mannosyltransferases form distinct protein complexes among themselves. J Biol Chem 2003; 278:12554 - 12562
   PubMed Web of Science ®Google Scholar
• Kuroda K, Kobayashi K, Kitagawa Y, Nakagawa T, Tsumura H, Komeda T, et al. Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minuta. Appl Environ Microbiol 2008; 74:446 - 453
   PubMed Web of Science ®Google Scholar
• Stadheim TA, Li H, Kett W, Burnina IN, Gerngross TU. Use of high-performance anion exchange chromatography with pulsed amperometric detection for O-glycan determination in yeast. Nat Protocols 2008; 3:1026 - 1031
   PubMed Web of Science ®Google Scholar
• Wang S, Ionescu R, Peekhaus N, Leung J, Ha S, Vlasak J. Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions. J Chrom A 2010; 1217:6496 - 6502
   PubMed Web of Science ®Google Scholar
• Ionescu R, Vlasak J, Price C, Kirchmeier M. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci 2008; 97:1414 - 1426
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J Biol Chem 2002; 277:26733 - 26740
   PubMed Web of Science ®Google Scholar
• Suzuki E, Niwa R, Saji S, Muta M, Hirose M, Iida S, et al. A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients. Clin Cancer Res 2007; 13:1875 - 1882
   PubMed Web of Science ®Google Scholar